ARCHIVES

Pas Available; Alternative Medicine

This article is from The Cancer Letter archive.

Vol. 20 No. 03 | January 21, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008